PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 88 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,601,833 | -10.9% | 347,332 | +23.0% | 0.96% | +18.2% |
Q2 2023 | $4,042,994 | +166.3% | 282,332 | +32.8% | 0.81% | +106.6% |
Q1 2023 | $1,518,071 | -30.9% | 212,615 | +8.5% | 0.39% | -30.9% |
Q4 2022 | $2,198,469 | +2.6% | 195,942 | +1.4% | 0.57% | +12.4% |
Q3 2022 | $2,142,000 | +31.2% | 193,326 | 0.0% | 0.51% | +11.9% |
Q2 2022 | $1,632,000 | -38.0% | 193,326 | 0.0% | 0.45% | -35.8% |
Q1 2022 | $2,631,000 | – | 193,326 | – | 0.71% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |